Isis 420915/GSK 299872
2015-P001574
Phase 2 small_molecule terminated
Quick answer
Isis 420915/GSK 299872 for Amyloidosis is a Phase 2 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IONIS PHARMACEUTICALS INC
- Indication
- Amyloidosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated